05/22/2024
7:55 AM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
7:55 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:09 AM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
05/15/2024
6:56 AM | Inhibikase Therapeutics (Filer)
| Form RW | |
05/09/2024
1:41 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
04/30/2024
7:17 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:20 PM | Inhibikase Therapeutics (Filer)
| Form ARS | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
04/26/2024
3:15 PM | Inhibikase Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
3:29 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
04/19/2024
4:14 PM | Inhibikase Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/18/2024
8:46 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
4:12 PM | Inhibikase Therapeutics (Filer)
| Form 8-K/A | |
04/02/2024
4:12 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
4:14 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:59 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:49 PM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
01/16/2024
3:31 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:15 PM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2023
4:24 PM | Inhibikase Therapeutics (Filer)
| Form 10-K/A | |
09/20/2023
10:23 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:29 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
8:11 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:12 PM | GRINT PAUL C (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:16 PM | Dion Gisele (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:18 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
11:15 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
6:08 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
